Longeveron (LGVN) EPS (Basic) (2020 - 2026)

Longeveron (LGVN) recorded quarterly EPS (Basic) of -$0.19 in Q1 2026, up 13.64% quarter-over-quarter from -$0.22 in Q4 2025, and up 44.12% on a YoY basis from -$0.13 in Q1 2025.

Longeveron (LGVN) EPS (Basic) (2020 - 2026) Analysis & Trends

Longeveron's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.19 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 44.12% year-over-year to -$0.19; the TTM figure through Mar 2026 stood at -$1.13 (up 53.31% YoY), while the FY2025 annual figure was -$1.29, up 50.76% from the prior year.
  • EPS (Basic) was -$0.19 for Q1 2026 at Longeveron, up from -$0.22 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.09 in Q4 2024 to a low of -$2.93 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$0.98 across 5 years, with a median of -$0.34 in 2024.
  • The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 1295.24% in 2023, then surged 103.07% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.21 in 2022, then sank by 1295.24% to -$2.93 in 2023, then jumped by 103.07% to $0.09 in 2024, then plunged by 344.44% to -$0.22 in 2025, then advanced by 13.64% to -$0.19 in 2026.
  • The last three EPS (Basic) figures came in at -$0.19 (Q1 2026), -$0.22 (Q4 2025), and -$0.39 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -0.68
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.06
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 0.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 4.06
9 Abivax 91.96 Bn 91.96 Bn - -0.06
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 -0.19

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.19
Dec 31, 2025 -0.22
Sep 30, 2025 -0.39
Jun 30, 2025 -0.33
Mar 31, 2025 -0.34
Dec 31, 2024 0.09
Sep 30, 2024 -0.34
Jun 30, 2024 -1.83
Mar 31, 2024 -1.61
Dec 31, 2023 -2.93
Sep 30, 2023 -2.79
Jun 30, 2023 -2.67
Mar 31, 2023 -2.21
Dec 31, 2022 -0.21
Sep 30, 2022 -0.25
Jun 30, 2022 -0.27
Mar 31, 2022 -0.17
Dec 31, 2021 -0.20
Sep 30, 2021 -0.25
Jun 30, 2021 -0.26